Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Director bought 168 shares at an average $5.11 ($858)
  2. 4 Open-market buy Director bought 84 shares at an average $5.11 ($429)
  3. 4 Open-market buy Chairman and CEO bought 168 shares at an average $5.11 ($858)
  4. 4 Open-market buy Director bought 93 shares at an average $4.48 ($417)
  5. 4 Open-market buy Director bought 186 shares at an average $4.48 ($833)
  6. 4 Open-market buy Chairman and CEO bought 186 shares at an average $4.48 ($833)
  7. 4 Open-market buy Director bought 1,035 shares at an average $4.48 ($4,635)
  8. 4 Open-market buy Director bought 74 shares at an average $5.18 ($384)
  9. 4 Open-market buy Director bought 168 shares at an average $5.24 ($881)
  10. 4 Open-market buy Chairman and CEO bought 168 shares at an average $5.24 ($881)
  11. 4 Open-market buy Director bought 875 shares at an average $5.20 ($4,548)
  12. 4 Grant or award Director acquired 1,000 shares (grant or award)
  13. 4 Grant or award Director acquired 5,000 shares (grant or award)
  14. 4 Grant or award Director acquired 1,000 shares (grant or award)
  15. 4 Grant or award Director acquired 1,000 shares (grant or award)
  16. 4 Grant or award Director acquired 1,000 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes Chairman and CEO gave up 3,558 shares (to pay taxes)

Page 3 of 26 · 512 filings